SEC Tracker
Get the app

Balance Labs BLNC

Balance Labs FY 2021: revenue $625K, down 38%; diluted EPS −$0.04

Form
10-K
Filed
Period
Importance
Notable
Document
10-K
Exhibit 10.6
Material contract
Exhibit 10.7
Material contract
Exhibit 10.8
Material contract

Key figures from this report

These are the numbers Balance Labs reported for the year ended Dec 31, 2021, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

  1. Revenue$625K−38% from $1.0M in FY 202010-K income statement, on EDGAR
  2. Net income−$797K−323% from $358K in FY 202010-K income statement, on EDGAR
  3. Diluted EPS−$0.04−300% from $0.02 in FY 202010-K income statement, on EDGAR
  4. Cash and cash equivalents$228K+3940% from $6K in FY 2020Cash and equivalents only; the company page adds short-term investments.10-K balance sheet, on EDGAR
  5. Cash from operations−$57KAgainst −$218K in FY 202010-K cash flow statement, on EDGAR

Every year in the financial tables

View on EDGAR

Open in the app

Get an email when Balance Labs files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 8742 and related industry codes: the same peer list as the financial tables.

  1. Yellowstone Group YSGL
  2. Bodhi Tree Biotechnology BDTB
  3. Vertical Data VDTA public float $2M, Mar 31, 2025, over 18 months old
  4. 1847 Holdings LBRA public float $2M, Jun 30, 2025
  5. Greenpro Capital GRNQ public float $8M, Jun 30, 2025